Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 3/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 3/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | FABP4 | P15090 | 2/20 | 0.35 |
| ▸ | PPARG | P37231 | 2/20 | 0.35 |
| ▸ | PPARD | Q03181 | 2/20 | 0.35 |
| ▸ | PPARA | Q07869 | 2/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL816236 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 | |
| SCHEMBL817634 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 | |
| SCHEMBL816463 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 | |
| SCHEMBL815521 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 | |
| SCHEMBL815515 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 | |
| SCHEMBL817359 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 | |
| SCHEMBL980997 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 | |
| SCHEMBL817299 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 | |
| SCHEMBL816919 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 | |
| SCHEMBL817952 | 0.97 | TSHR (0.44) | TSHRFAAHTRPV1TERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 461 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11548900-B2 | Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof | BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) | 2023-01-10 | — | — | US | claimed |
| EP-3760633-B1 | OXAZINO-QUINAZOLINE AND OXAZINO-QUINAZOLINE TYPE COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF | BEIJING SCITECH MQ PHARMACEUTICALS LTD (CN) | 2021-12-15 | — | — | EP | claimed |
| US-11091474-B2 | Alkoxy bis-heteroaryl derivatives as modulators of protein aggregation | UCB Biopharma SRL (BE) | 2021-08-17 | — | — | US | claimed |
| CN-110229171-B | Oxazinoquinazoline and oxazinoquinoline compound and preparation method and application thereof | 北京赛特明强医药科技有限公司 | 2021-03-12 | — | — | CN | claimed |
| US-20210040114-A1 | OXAZINO-QUINAZOLINE AND OXAZINO-QUINOLINE TYPE COMPOUND, PREPARATION METHOD AND USES THEREOF | ACCSALUS BIOSCIENCES LIMITED (VG) | 2021-02-11 | — | — | US | claimed |
| EP-3760633-A1 | OXAZINO-QUINAZOLINE AND OXAZINO-QUINAZOLINE TYPE COMPOUND, PREPARATION METHOD THEREFOR, AND USES THEREOF | Beijing Scitech-MQ Pharmaceuticals Limited (CN) | 2021-01-06 | — | — | EP | claimed |
| CN-111718332-A | 2-substituted pyrazol amino-4-substituted amino-5-pyrimidine formamide compound, composition and application thereof | 北京赛特明强医药科技有限公司 | 2020-09-29 | — | — | CN | claimed |
| WO-2020187292-A1 | 2-SUBSTITUTED PYRAZOLEAMINO-4-SUBSTITUTED AMINO-5-PYRIMIDINE FORMAMIDE COMPOUND, COMPOSITION AND USE THEREOF | 北京赛特明强医药科技有限公司 | 2020-09-24 | — | — | WO | claimed |
| US-20200291013-A1 | ALKOXY BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION | UCB BIOPHARMA SPRL (BE) | 2020-09-17 | — | — | US | claimed |
| CN-110229171-A | A kind of oxazines and quinazoline and oxazines and quinolines and its preparation method and application | 北京赛特明强医药科技有限公司 | 2019-09-13 | — | — | CN | claimed |
| CN-110191885-A | ALKOXY BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION | UCB生物制药私人有限公司 | 2019-08-30 | — | — | CN | claimed |
| WO-2018138085-A1 | ALKOXY BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION | UCB BIOPHARMA SPRL (BE) | 2018-08-02 | — | — | WO | claimed |
| US-20030130398-A1 | Soft polymeric compounds including metal oxide fillers | BRIDGESTONE CORPORATION | 2003-07-10 | — | — | US | claimed |
| US-6369166-B1 | PLASTICIZED; TENSILE AND TEAR STRENGTH; ELONGATION; HIGH DAMPING; ETHYLENE-MALEIC ANHYDRIDE COPOLYMER REACTED WITH PRIMARY AMINE | BRIDGESTONE CORPORATION (JP) | 2002-04-09 | — | — | US | claimed |
| US-20010021743-A1 | Method of producing a graft copolymer | BRIDGESTONE CORPORATION (JP) | 2001-09-13 | — | — | US | claimed |
| US-6207763-B1 | A COPOLYMER OF SUBSTITUTED OR UNSUBSTITUTED 1-20 ALKYL GROUP DISUBSTITUTED ETHYLENE-MALEIMIDE COPOLYMER(A REACTION PRODUCT OF DISUBTITUTED ETHYLENE-MALEIC ANHYDRIDE IMIDIZED WITH PRIMARY AMINE) IS A PLASTICIZER FOR RUBBER; HIGH DAMPING | BRIDGESTONE CORPORATION (JP) | 2001-03-27 | — | — | US | claimed |
| US-6204354-B1 | DRY ENVIRONMENT | BRIDGESTONE CORPORATION (JP) | 2001-03-20 | — | — | US | claimed |
| US-6191217-B1 | REACTING POLY(ALKYL VINYLETHER-CO-MALEIMIDE) POLYMER WITH MALEATED POLYALKYLENE AND ALKYL DIAMINE UNDER SUBSTANTIALLY DRY CONDITIONS SUFFICIENT TO FORM POLYALKYLENE GRAFTED POLY(ALKYL VINYLETHER-CO-MALEIMIDE) POLYMER | BRIDGESTONE CORPORATION (JP) | 2001-02-20 | — | — | US | claimed |
| US-6133354-A | MIXING A POLY(DIALKYLSUBSTITUTED ETHYLENE-CO-MALEIMIDE) POLYMER SUCH AS POLYISOBUTYLENE-CO-MALEIMIDE, AND PLASTICIZERS OR EXTENDERS WITHIN A NON-VULCANIZED THERMOPLASTIC ELASTOMER TO FORM A DAMPING GEL; TENSILE STRENGTH AND TEAR STRENGTH | BRIDGESTONE CORPORATION (JP) | 2000-10-17 | — | — | US | claimed |
| EP-0955319-A1 | Soft compounds derived from polypropylene grafted disubstituted ethylene-maleimide copolymers | Bridgestone Corporation (JP) | 1999-11-10 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200291013-A1 | ALKOXY BIS-HETEROARYL DERIVATIVES AS MODULATORS OF PROTEIN AGGREGATION | PARK7, HTT, SNCA | TSHR 3836/4885LPAR3 447/4885FAAH 2699/4885 |
| US-11548900-B2 | Oxazino-quinazoline and oxazino-quinoline type compound, preparation method and uses thereof | WNK1, WNK2, WNK3 | TSHR 4235/4885LPAR3 2830/4885FAAH 2485/4885 |
| US-11091474-B2 | Alkoxy bis-heteroaryl derivatives as modulators of protein aggregation | PARK7, HTT, SNCA | TSHR 3836/4885LPAR3 447/4885FAAH 2699/4885 |
| US-20210040114-A1 | OXAZINO-QUINAZOLINE AND OXAZINO-QUINOLINE TYPE COMPOUND, PREPARATION METHOD AND USES THEREOF | WNK1, WNK2, WNK3 | TSHR 4235/4885LPAR3 2830/4885FAAH 2485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.